1991
DOI: 10.4269/ajtmh.1991.44.413
|View full text |Cite
|
Sign up to set email alerts
|

Immune Response and Trypanosoma Cruzi Infection in Trypanosoma Rangeli-Immunized Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

7
27
0
2

Year Published

1997
1997
2015
2015

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 28 publications
(36 citation statements)
references
References 0 publications
7
27
0
2
Order By: Relevance
“…For endemic regions in Panama, T. rangeli is more frequently found in human blood than T. cruzi 23 . In this sense, recent data have shown that complete or partial immunity against T. cruzi can be obtained in animal models previously immunized with low virulent T. cruzi strains 5,9 or with T. rangeli 1,29 . The fact that more than one T. cruzi strain 10,16 and even more than one Trypanosoma species 6,23 can be transmitted by R. pallescens in Panama makes this possibility feasible.…”
Section: Discussionmentioning
confidence: 99%
“…For endemic regions in Panama, T. rangeli is more frequently found in human blood than T. cruzi 23 . In this sense, recent data have shown that complete or partial immunity against T. cruzi can be obtained in animal models previously immunized with low virulent T. cruzi strains 5,9 or with T. rangeli 1,29 . The fact that more than one T. cruzi strain 10,16 and even more than one Trypanosoma species 6,23 can be transmitted by R. pallescens in Panama makes this possibility feasible.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, mice immunized with fixed T. rangeli epimastigotes had significantly lower parasitemias and longer survival than controls when infected with virulent T. cruzi trypomastigotes (Basso et al 1991, Introini et al 1998). …”
Section: Discussionmentioning
confidence: 99%
“…Although considered non-pathogenic to man [1], T. rangeli is of medical interest as a possible source of confusion in the serological diagnosis of Chagas' disease due to its well-known immunological cross-reactivity with T. cruzi [2][3][4][5]. In experimental infection of mice, several exposures to T. rangeli cause an increase in antibody titres to T. cruzi and it is possible that these antibodies modulate the outcome of active T. cruzi infection [6][7][8][9]. In support of this notion, Chagas' disease acquires its mildest clinical manifestation precisely in geographical areas in which insect vectors of Chagas' disease have high infection rates with T. rangeli [10].…”
Section: Introductionmentioning
confidence: 99%